Sopharma News
Sopharma’s smoking cessation drug with positive preliminary clinical trial data in the US
Sopharma’s (3JR BU) smoking cessation drug with positive preliminary clinical trial data in the US, the Company’s American partner Achieve Life Sciences (NASDAQ: ACHV) announced in a statement. Achieve acquired the rights to commercialize Sopharma’s Tabex in the US in 2015. In 2017 it initiated an Investigational New Drug application with the US Food and Drug Administration and commenced a cytisine clinical development program in preparation to initiate ...
read more
Video clip and Internet site in support of the Bulgarian application to host the European Medicine Agency
Bulgaria is among the 19 candidates for hosting the European Medicine Agency (EMA), which – in connection with Brexit - will change its headquarters next year. The Bulgarian government has presented a site and a video clip on the country's application which can be found at According to the information there contained, the Bulgarian pharmaceutical sector can boast with 12,000 highly qualified professionals and since the mi...
read more
A representative of Sopharma AD of was elected to the Executive bureau of MEDICINES FOR EUROPE for a third consecutive term
The director of the department of ”Business operations, strategic and organizational development” at “Sopharma” AD, Mr. Vladimir Afenliev, was unanimously elected at the general assembly of “MEDICINES FOR EUROPE” (the former EGA) held at the end of June in Lisbon. This is the third consecutive mandate for Mr. Afenliev; during the previous term he also served as vice-president of the Executive bureau. The election of Mr. Afenliev is an impressive recognition of t...
read more